CUAMC
HRMY icon

China Universal Asset Management Company’s Harmony Biosciences HRMY Stock Holding History

China Universal Asset Management Company’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$287K Buy
10,264
+879
+9% +$28.8K 0.02% 319
2025
Q4 		$351K Sell
9,385
-700
-7% -$23K 0.03% 287
2025
Q3 		$278K Sell
10,085
-1,448
-13% -$49.9K 0.02% 304
2025
Q2 		$364K Buy
11,533
+30
+0.3% +$965 0.03% 269
2025
Q1 		$382K Sell
11,503
-590
-5% -$21.1K 0.04% 266
2024
Q4 		$416K Buy
12,093
+1,162
+11% +$39.9K 0.04% 267
2024
Q3 		$437K Buy
10,931
+4,259
+64% +$150K 0.05% 237
2024
Q2 		$201K Sell
6,672
-4,221
-39% -$127K 0.03% 244
2024
Q1 		$366K Buy
10,893
+4,116
+61% +$132K 0.05% 213
2023
Q4 		$219K Buy
6,777
+5,244
+342% +$146K 0.04% 197
2023
Q3 		$50.2K Buy
1,533
+748
+95% +$26K 0.01% 232
2023
Q2 		$27.6K Sell
785
-22
-3% -$759 0.01% 240
2023
Q1 		$26.3K Buy
807
+204
+34% +$9.29K 0.01% 195
2022
Q4 		$33.2K Buy
603
+49
+9% +$2.69K 0.01% 152
2022
Q3 		$25K Buy
+554
New +$27K 0.01% 144

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

China Universal Asset Management Company's HRMY Position: Q1 2026 in Review

China Universal Asset Management Company increased its Harmony Biosciences (HRMY) stake by 9.4% in Q1 2026, buying an estimated $28.8K and bringing the position to 10,264 shares worth $287K. The position accounts for 0.02% of the portfolio, ranked #319.

China Universal Asset Management Company first reported a position in HRMY in Q3 2022 and has held it in 15 quarters since. The position peaked at $437K in Q3 2024. 309 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • China Universal Asset Management Company held 10,264 shares of Harmony Biosciences worth $287K as of Q1 2026.
  • China Universal Asset Management Company bought 879 Harmony Biosciences shares in Q1 2026, an estimated $28.8K.
  • Harmony Biosciences made up 0.02% of China Universal Asset Management Company's portfolio in Q1 2026, its #319 holding.
  • China Universal Asset Management Company first reported a position in Harmony Biosciences in Q3 2022 and has held it in 15 quarters since.
  • China Universal Asset Management Company's Harmony Biosciences position peaked at $437K in Q3 2024.
  • 309 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on China Universal Asset Management Company's 13F filing for Q1 2026, filed 28 Apr 2026.